Outcomes4Me Cancer Care user reviews, decoded

Low confidence · Latest 60 of 84 total reviews analyzed · Based on 84 reviews. Signal may be noisy.

Mixed

Recent user voice shows a mixed sentiment. Users appreciate evidence-based medical information helps patients formulate intelligent questions for their oncology appointments and compassionate design provides a supportive resource for those feeling overwhelmed by their diagnosis, but report limited support for rare cancer types creates frustration for patients seeking specific information.

Rating: 4.0

Reviews: 84

Confidence: low

How did the latest release land?

Overall
3.8/ 5
★★★★★
(651)
Current version
4.3/ 5
+0.5 vs overall
★★★★★★
(154)
Main signal post-update: evidence-based medical information helps patients formulate intelligent questions for their oncology appointments.

Sentiment over time

Weekly average rating and review volume across stores, last 90 days.

How have ratings & review volume moved?

Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.

Review sentiment over time

Vertical markers = app releases. Hover any release for the post-release impact delta.

Review themes

Praise

What users love

  • Evidence-based medical information helps patients formulate intelligent questions for their oncology appointments
  • Compassionate design provides a supportive resource for those feeling overwhelmed by their diagnosis
Complaint

Common complaints

  • Limited support for rare cancer types creates frustration for patients seeking specific information
Request

Most requested

Full sentiment breakdown

Access the full report for free

AI summary. Key signals synthesized from the latest 84 reviews. Updated regularly.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Outcomes4Me Cancer Care, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0